Share Facebook Twitter LinkedIn Pinterest Telegram Email Bristol Myers Squibb and Cellares enter into $380 million CAR-T therapy deal Source link See also DiaMedica Cuts Oppenheimer Target to $6 Due to Litigation Delay From Investing.com Bristol CART Cellares deal enter Million Myers Squibb
ZKsync approves proposal to distribute 325 million ZK tokens to boost liquidity across chainsNovember 14, 2024
